SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest

Rhea-AI Summary

BILLERICA, Mass., March 24, 2022 – SeqLL Inc. (NASDAQ: SQL; SQLLW) announced its CEO, Daniel Jones, will participate in the 2022 Virtual Growth Conference from March 28-30, 2022. The presentation will be available on demand starting at 9:00 am ET on March 28. Interested attendees can register for the event, and the archived webcast will be accessible on the Company’s investor relations website. SeqLL specializes in life sciences instrumentation and research services, focusing on advancing genomic medicine through its True Single Molecule Sequencing platform.

BILLERICA, Mass., March 24, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that Daniel Jones, CEO of SeqLL will participate at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, taking place on March 28-30, 2022.

The presentation will be available on demand beginning at 9:00 am ET on Monday, March 28^th. To register and attend the event, please click HERE. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About SeqLL Inc.
SeqLL Inc. (“SeqLL”) is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple “omics” fields. The Company leverages its expertise with its True Single Molecule Sequencing (“tSMS®”) platform to empower scientists and researchers with improved genetic tools to better understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with today’s precision medicine. In sum, our experienced team works with our collaborators to develop innovative solutions tailored to the needs of each specific project.

Contacts:
Ashley R. Robinson
LifeSci Advisors, LLC
Tel: +1 (617) 430-7577
Email: arr@lifesciadvisors.com

FAQ

When will Daniel Jones speak at the 2022 Virtual Growth Conference?

Daniel Jones will present at the 2022 Virtual Growth Conference from March 28-30, 2022.

How can I register for SequLL's presentation at the conference?

You can register for SeqLL's presentation at the conference through the link provided in their press release.

What is the focus of SeqLL Inc.'s technology?

SeqLL Inc. focuses on life sciences instrumentation and research services, particularly in the field of genomic medicine.

What is the True Single Molecule Sequencing platform?

The True Single Molecule Sequencing (tSMS®) platform by SeqLL enables improved genetic tools for understanding disease mechanisms.

Where can I find the archived webcast of SeqLL's presentation?

The archived webcast will be available on SeqLL's investor relations website on the Events & Presentations page.